Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).
about
Adjuvant chemotherapy for advanced endometrial cancerChemotherapy for advanced, recurrent or metastatic endometrial carcinomaImmunohistochemical profile for unknown primary adenocarcinoma.Feasibility study of paclitaxel plus carboplatin in patients with endometrial cancer: a Japan Kanto Tumor Board study (JKTB trial).The prognostic impact of pulmonary metastasectomy in recurrent gynecologic cancers: a retrospective single-institution study.Aqueous Extract of Solanum nigrum Leaf Activates Autophagic Cell Death and Enhances Docetaxel-Induced Cytotoxicity in Human Endometrial Carcinoma Cells.Combination chemotherapy with docetaxel and carboplatin for elderly patients with endometrial cancerThioridazine enhances sensitivity to carboplatin in human head and neck cancer cells through downregulation of c-FLIP and Mcl-1 expression.The clinical management of inoperable endometrial carcinoma.Adjuvant docetaxel and carboplatin chemotherapy administered alone or with radiotherapy in a "sandwich" protocol in patients with advanced endometrial cancer: a single-institution experience.Triple simultaneous primary invasive gynecological malignancies: a case report.
P2860
Q24194639-D45BF4A0-FB76-4F78-877B-3B280972481EQ24201586-2922C7B7-3C29-4EF0-A00C-F623D0D1D618Q31047832-37829CF6-7BFB-426F-9EAB-1CC6540FC8EDQ33401454-30CFD31D-E958-4FAA-A85D-68DA7B1078C0Q36071462-9BF7C75F-A75C-4957-944F-FED2EB470DD7Q36477744-77AA6C5F-2A46-4208-8A7D-BEDE9E33AA7EQ36824698-C8752940-E06D-4B03-91A6-047A244F4419Q37745302-A2D91559-E66B-4233-9771-0CBD95E097DDQ38783340-DB1D714C-844A-4982-8598-C0477F015968Q45952515-5369E950-14FC-43B0-B9A1-50A35138E3C2Q53101122-E41AB629-544A-4B2E-B971-8E14A294F62D
P2860
Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Randomized phase II study comp ...... cology Group study (JGOG2041).
@ast
Randomized phase II study comp ...... cology Group study (JGOG2041).
@en
type
label
Randomized phase II study comp ...... cology Group study (JGOG2041).
@ast
Randomized phase II study comp ...... cology Group study (JGOG2041).
@en
prefLabel
Randomized phase II study comp ...... cology Group study (JGOG2041).
@ast
Randomized phase II study comp ...... cology Group study (JGOG2041).
@en
P2093
P356
P1433
P1476
Randomized phase II study comp ...... cology Group study (JGOG2041).
@en
P2093
F Takahashi
N Katsumata
N Yaegashi
Y Watanabe
P304
P356
10.1093/ANNONC/MDQ401
P577
2010-08-09T00:00:00Z